Michelle Harlan, who has sickle beta thalassemia, wants to help others by getting a doctoral degree in clinical psychology.

Beam Therapeutics reported promising Phase 1/2 data for BEAM-302, demonstrating durable gene correction for AATD. See why I ...

Carlyle Group's acquisition of bluebird bio for $3 per share offers a potential but unlikely $600 million sales milestone by ...

I am 71, and I recently saw my urologist for urinating a lot and not getting enough sleep. He performed a flow test and a ...

Editor’s note: Floridians are paying a lot of money for health insurance, but we’ve been listening to our viewers. Many of you are very unhappy with your coverage. At ABC Action News, we want ...

A single molecular switch is essential for blood stem cells to enter an activated, regenerative state in which they produce new blood cells, according to a preclinical study led by Weill Cornell ...

Problems with iron levels in the blood and the body's ability to regulate this important nutrient as a result of SARS-CoV-2 infection could be a key trigger for long COVID, new research has ...

Agios is advancing a robust clinical pipeline of investigational medicines with programs in alpha- and beta-thalassemia, sickle cell disease, pediatric PK deficiency, myelodysplastic syndromes ...

Thalassemia, a genetic blood disorder, affects thousands of people in Telangana and Hyderabad, yet awareness and understanding of the condition remain limited. We spoke to Chandrakant Agarwal ...

Christopher A. Farrell is a bestselling author, and former Wall Street trader and market maker with nearly 30 years of experience, trading over $20 billion in transaction value over his career.